Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California-Reference-Cited by-同舟云学术

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California

Published:2021-07-31 Issue:16 Volume:10 Page:5671-5680
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Salgia Nicholas J.¹^ORCID,Chehrazi‐Raffle Alexander¹^ORCID,Hsu JoAnn¹,Zengin Zeynep¹,Salgia Sabrina¹,Chawla Neal S.¹,Meza Luis¹,Malhotra Jasnoor¹,Dizman Nazli¹^ORCID,Muddasani Ramya²,Ruel Nora³,Cianfrocca Mary¹,Gong Jun⁴^ORCID,Anand Sidharth⁵,Chiu Victor⁶,Yeh James⁷,Pal Sumanta K.¹^ORCID

Affiliation:

1. Department of Medical Oncology & Experimental TherapeuticsCity of Hope Comprehensive Cancer Center Duarte CA USA

2. Department of Medicine City of Hope Comprehensive Cancer Center Duarte CA USA

3. Biostatistics and Mathematical Modeling CoreCity of Hope Comprehensive Cancer Center Duarte CA USA

4. Division of Hematology/OncologyDepartment of MedicineCedars‐Sinai Medical Center Los Angeles CA USA

5. Division of Hematology/OncologyDavid Geffen School of Medicine at UCLA Los Angeles CA USA

6. Division of Hematology/Oncology UCLA‐Olive View Medical Center Los Angeles CA USA

7. Division of Hematology and Medical Oncology Department of Medicine Harbor‐UCLA Medical Center Torrance CA USA

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4119

Reference30 articles.

1. NCI‐Designated Cancer Centers. National Cancer Institute.https://www.cancer.gov/research/infrastructure/cancer‐centers. Accessed May 3 2021.

2. Impact of care at comprehensive cancer centers on outcome: Results from a population-based study

3. Association of national cancer institute‐sponsored clinical trial network group studies with guideline care and new drug indications;Unger JM;JAMA,2019

4. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants;JCO Oncology Practice;2024-09

2. Barriers to Clinical Trial Implementation Among Community Care Centers;JAMA Network Open;2024-04-29

3. Clinical Network Systems Biology: Traversing the Cancer Multiverse;Journal of Clinical Medicine;2023-07-07